Stepping Out of Line in Stem Cell Research
By Daniel Sarewitz,
Los Angeles Times
| 10. 25. 2004
Proposition 71 would cut the link between science and democracy
Proposition 71 would cut the link between science and democracy.
Daniel Sarewitz is a professor of science and society at Arizona State University and director of its Consortium for Science, Policy, and Outcomes.
October 25, 2004
There's no doubt that the emerging revolution in life sciences will profoundly transform society in the coming decades. The question Californians now need to ask themselves is whether they want to abdicate control of this transformation and hand it over entirely to scientists and the private sector. If they do, then Proposition 71, the California Stem Cell Research and Cures Act, is the way to go.
Biomedical scientists, patient advocacy groups and others have reason to be frustrated by the restrictions President Bush has placed on stem cell research. But Proposition 71 asks voters to cure these frustrations by undermining their own democratic safeguards and institutions.
see moreProposition 71 creates an unprecedented state constitutional "right to conduct stem cell research." It sets aside $3 billion of public spending for stem cell research _ and then insulates that money from meaningful public or legislative accountability. It...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Charles Schmidt, Undark | 09.25.2026
In 2010, scientists at the University of Tokyo and other institutions reported a startling achievement: They had successfully grown a pancreas made almost entirely of rat cells within the bodies of mice. The research was directed by Hiromitsu Nakauchi, a...
By Editors, Nature | 08.18.2026
Shinya Yamanaka doesn’t see himself as a celebrity. But people do recognize the stem-cell researcher when he’s out for a run, often while training for a marathon, on the streets of Kyoto, Japan.
Many of them call out words of...
By Jessica Hamzelou, MIT Technology Review | 07.30.2026
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to...